<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/57"/><api:result><api:object category="publication" id="57" last-affected-when="2024-03-17T08:51:23.423+00:00" last-modified-when="2024-03-17T08:51:23.423+00:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/57" created-when="2010-05-17T13:46:10.247+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2009-07-01</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1918209" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.3109/10428199809059253" last-modified-when="2022-09-11T23:04:27.783+01:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Shipman</api:last-name><api:initials>CM</api:initials><api:first-names>Claire M</api:first-names><api:separate-first-names><api:first-name>Claire</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Rogers</api:last-name><api:initials>MJ</api:initials><api:first-names>Michael J</api:first-names><api:separate-first-names><api:first-name>Michael</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>Jane F</api:first-names><api:separate-first-names><api:first-name>Jane</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Russell</api:last-name><api:initials>RGG</api:initials><api:first-names>R Graham G</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>Graham</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>Peter I</api:first-names><api:separate-first-names><api:first-name>Peter</api:first-name><api:first-name>I</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.3109/10428199809059253</api:text><api:links><api:link type="doi" href="http://doi.org/10.3109/10428199809059253"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.3109/10428199809059253"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1029-2403</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974230"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1042-8194</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974230"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>1-2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Leukemia &amp;amp; Lymphoma</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:month>7</api:month><api:year>2009</api:year></api:date></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>129</api:begin-page><api:end-page>138</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>1</api:month><api:year>1998</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Informa UK Limited</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.3109/10428199809059253</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>15</api:day><api:month>9</api:month><api:year>2020</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Anti-Tumour Activity of Bisphosphonates in Human Myeloma Cells</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>32</api:text></api:field></api:native></api:record><api:record format="native" id="93993" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0032450839" last-modified-when="2023-11-22T06:23:38.8+00:00"><api:citation-count>28</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Multiple myeloma is a haematological malignancy characterized by an expansion of malignant plasma cells within the bone marrow and is frequently associated with bone disease involving the development of osteolytic bone lesions, pathological fractures, osteoporosis and hypercalcaemia. A class of anti-resorptive drugs known as bisphosphonates have been in use to treat osteoclast-mediated bone diseases for the past 3 decades, and are currently proving effective in the treatment of the bone disease associated with multiple myeloma. Recent studies have suggested that bisphosphonate treatment may also result in an improvement in survival in some patients with multiple myeloma. These effects on survival may reflect an indirect effect of the bisphosphonates on tumour growth, via inhibition of osteoclast activity and hence a reduction in the release of tumour growth factors. However, it is also possible that bisphosphonates may have a direct effect on myeloma cells. In support of this we have demonstrated that bisphosphonates can decrease cell proliferation and induce apoptosis in human myeloma cells in vitro, and this review discusses the possibility that bisphosphonates may have not only an anti-resorptive action, but may also have a direct anti-tumour activity.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Shipman</api:last-name><api:initials>CM</api:initials><api:first-names>CM</api:first-names><api:separate-first-names><api:first-name>C</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Aberdeen School of Medicine, Medical Sciences and Nutrition</api:line><api:line type="city">Aberdeen</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">The University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7006186714</api:identifier></api:identifiers></api:person><api:person><api:last-name>Rogers</api:last-name><api:initials>MJ</api:initials><api:first-names>MJ</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Aberdeen School of Medicine, Medical Sciences and Nutrition</api:line><api:line type="city">Aberdeen</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55481881300</api:identifier></api:identifiers></api:person><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>JF</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>F</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">UCL Cancer Institute</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005558171</api:identifier></api:identifiers></api:person><api:person><api:last-name>Russell</api:last-name><api:initials>RGG</api:initials><api:first-names>RGG</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>G</api:first-name><api:first-name>G</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Aberdeen School of Medicine, Medical Sciences and Nutrition</api:line><api:line type="city">Aberdeen</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">The University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7403934359</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>PI</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>I</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Aberdeen School of Medicine, Medical Sciences and Nutrition</api:line><api:line type="city">Aberdeen</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">The University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">The Sheffield Medical School</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">26635094100</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.3109/10428199809059253</api:text><api:links><api:link type="doi" href="http://doi.org/10.3109/10428199809059253"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.3109/10428199809059253"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10037008</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1042-8194</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974230"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>1-2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Leukemia and Lymphoma</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>129</api:begin-page><api:end-page>138</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>1</api:month><api:year>1998</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Anti-tumour activity of bisphosphonates in human myeloma cells</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Review</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>32</api:text></api:field></api:native></api:record><api:record format="native" id="57" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10037008" last-modified-when="2020-04-29T00:29:10.133+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Multiple myeloma is a haematological malignancy characterized by an expansion of malignant plasma cells within the bone marrow and is frequently associated with bone disease involving the development of osteolytic bone lesions, pathological fractures, osteoporosis and hypercalcaemia. A class of anti-resorptive drugs known as bisphosphonates have been in use to treat osteoclast-mediated bone diseases for the past 3 decades, and are currently proving effective in the treatment of the bone disease associated with multiple myeloma. Recent studies have suggested that bisphosphonate treatment may also result in an improvement in survival in some patients with multiple myeloma. These effects on survival may reflect an indirect effect of the bisphosphonates on tumour growth, via inhibition of osteoclast activity and hence a reduction in the release of tumour growth factors. However, it is also possible that bisphosphonates may have a direct effect on myeloma cells. In support of this we have demonstrated that bisphosphonates can decrease cell proliferation and induce apoptosis in human myeloma cells in vitro, and this review discusses the possibility that bisphosphonates may have not only an anti-resorptive action, but may also have a direct anti-tumour activity.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Shipman</api:last-name><api:initials>CM</api:initials><api:first-names>CM</api:first-names><api:separate-first-names><api:first-name>C</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Department of Medicine and Therapeutics, University of Aberdeen Medical School, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Rogers</api:last-name><api:initials>MJ</api:initials><api:first-names>MJ</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>JF</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Graham</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="18810" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18810"/></api:links><api:last-name>Russell</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>PI</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>I</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10037008</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.3109/10428199809059253</api:text><api:links><api:link type="doi" href="http://doi.org/10.3109/10428199809059253"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.3109/10428199809059253"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1042-8194</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974230"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>1-2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Leuk Lymphoma</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Antineoplastic Agents</api:keyword><api:keyword scheme="mesh">Apoptosis</api:keyword><api:keyword scheme="mesh">Bone Diseases</api:keyword><api:keyword scheme="mesh">Cell Count</api:keyword><api:keyword scheme="mesh">Diphosphonates</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Multiple Myeloma</api:keyword><api:keyword scheme="mesh">Survival</api:keyword><api:keyword scheme="mesh">Tumor Cells, Cultured</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>United States</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>129</api:begin-page><api:end-page>138</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>12</api:month><api:year>1998</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>29</api:day><api:month>6</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Anti-tumour activity of bisphosphonates in human myeloma cells.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Review</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>32</api:text></api:field></api:native></api:record><api:record format="native" id="849951" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10037008" last-modified-when="2023-09-13T00:15:19.217+01:00"><api:citation-count>15</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Multiple myeloma is a haematological malignancy characterized by an expansion of malignant plasma cells within the bone marrow and is frequently associated with bone disease involving the development of osteolytic bone lesions, pathological fractures, osteoporosis and hypercalcaemia. A class of anti-resorptive drugs known as bisphosphonates have been in use to treat osteoclast-mediated bone diseases for the past 3 decades, and are currently proving effective in the treatment of the bone disease associated with multiple myeloma. Recent studies have suggested that bisphosphonate treatment may also result in an improvement in survival in some patients with multiple myeloma. These effects on survival may reflect an indirect effect of the bisphosphonates on tumour growth, via inhibition of osteoclast activity and hence a reduction in the release of tumour growth factors. However, it is also possible that bisphosphonates may have a direct effect on myeloma cells. In support of this we have demonstrated that bisphosphonates can decrease cell proliferation and induce apoptosis in human myeloma cells in vitro, and this review discusses the possibility that bisphosphonates may have not only an anti-resorptive action, but may also have a direct anti-tumour activity.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Department of Medicine and Therapeutics, University of Aberdeen Medical School, UK.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Shipman</api:last-name><api:initials>CM</api:initials><api:first-names>CM</api:first-names><api:separate-first-names><api:first-name>C</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Rogers</api:last-name><api:initials>MJ</api:initials><api:first-names>MJ</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0002-1818-9249</api:identifier></api:identifiers></api:person><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>JF</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Graham</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="18810" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18810"/></api:links><api:last-name>Russell</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0002-4136-1828</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>PI</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>I</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0002-7102-2413</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.3109/10428199809059253</api:text><api:links><api:link type="doi" href="http://doi.org/10.3109/10428199809059253"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.3109/10428199809059253"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1029-2403</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974230"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10037008</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1042-8194</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974230"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>1-2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Leukemia &amp; lymphoma</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Multiple Myeloma</api:keyword><api:keyword scheme="mesh">Bone Diseases</api:keyword><api:keyword scheme="mesh">Diphosphonates</api:keyword><api:keyword scheme="mesh">Antineoplastic Agents</api:keyword><api:keyword scheme="mesh">Cell Count</api:keyword><api:keyword scheme="mesh">Apoptosis</api:keyword><api:keyword scheme="mesh">Survival</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>129</api:begin-page><api:end-page>138</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>12</api:month><api:year>1998</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>26</api:day><api:month>2</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Anti-tumour activity of bisphosphonates in human myeloma cells.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Review</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>32</api:text></api:field></api:native></api:record><api:record format="native" id="2920618" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1032553929" last-modified-when="2024-03-17T08:51:23.43+00:00"><api:citation-count>21</api:citation-count><api:native><api:field name="altmetric-attention-score" type="integer" display-name="Altmetric attention score"><api:integer>3</api:integer></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Shipman</api:last-name><api:initials>CM</api:initials><api:first-names>CM</api:first-names><api:separate-first-names><api:first-name>C</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Aberdeen</api:line><api:line type="city">Aberdeen</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01251142271.20</api:identifier></api:identifiers></api:person><api:person><api:last-name>Rogers</api:last-name><api:initials>MJ</api:initials><api:first-names>MJ</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.015422336762.36</api:identifier></api:identifiers></api:person><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>JF</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>F</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0753003365.31</api:identifier></api:identifiers></api:person><api:person><api:last-name>Graham</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01146066562.17</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="18810" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18810"/></api:links><api:last-name>Russell</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01170731671.71</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>PI</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>I</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0756766474.08</api:identifier></api:identifiers><api:author-types><api:author-type>corresponding</api:author-type></api:author-types></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.3109/10428199809059253</api:text><api:links><api:link type="doi" href="http://doi.org/10.3109/10428199809059253"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.3109/10428199809059253"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10037008</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1042-8194</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974230"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>1-2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Leukemia &amp; Lymphoma</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3201 Cardiovascular Medicine and Haematology</api:keyword><api:keyword scheme="rcdc">Rare Diseases</api:keyword><api:keyword scheme="rcdc">Hematology</api:keyword><api:keyword scheme="rcdc">Osteoporosis</api:keyword><api:keyword scheme="rcdc">Cancer</api:keyword><api:keyword scheme="hrcs-rac">5 Development of treatments and therapeutic interventions</api:keyword><api:keyword scheme="hrcs-rac">5.1 Pharmaceuticals</api:keyword><api:keyword scheme="hrcs-hc">Cancer</api:keyword><api:keyword scheme="hrcs-hc">Musculoskeletal</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Antineoplastic Agents</api:keyword><api:keyword scheme="mesh">Apoptosis</api:keyword><api:keyword scheme="mesh">Bone Diseases</api:keyword><api:keyword scheme="mesh">Cell Count</api:keyword><api:keyword scheme="mesh">Diphosphonates</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Multiple Myeloma</api:keyword><api:keyword scheme="mesh">Survival</api:keyword><api:keyword scheme="mesh">Tumor Cells, Cultured</api:keyword></api:keywords></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:month>7</api:month><api:year>2009</api:year></api:date></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Closed Access</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>129</api:begin-page><api:end-page>138</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>1</api:month><api:year>1998</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Taylor &amp; Francis</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.58</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Anti-Tumour Activity of Bisphosphonates in Human Myeloma Cells</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>32</api:text></api:field></api:native></api:record><api:record format="native" id="239743" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000078509300013" last-modified-when="2024-03-14T05:32:21.05+00:00"><api:citation-count>24</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Shipman</api:last-name><api:initials>CM</api:initials><api:first-names>CM</api:first-names><api:separate-first-names><api:first-name>C</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Rogers</api:last-name><api:initials>MJ</api:initials><api:first-names>MJ</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>JF</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Russell</api:last-name><api:initials>RGG</api:initials><api:first-names>RGG</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>G</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>PI</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>I</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000078509300013&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.3109/10428199809059253</api:text><api:links><api:link type="doi" href="http://doi.org/10.3109/10428199809059253"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.3109/10428199809059253"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1029-2403</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974230"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">165FE</api:identifier><api:identifier scheme="pubmed">10037008</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1042-8194</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974230"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>1-2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>LEUKEMIA &amp; LYMPHOMA</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>multiple myeloma</api:keyword><api:keyword>bisphosphonates</api:keyword><api:keyword>apoptosis</api:keyword><api:keyword>bone disease</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>129</api:begin-page><api:end-page>138</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1998</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Anti-tumour activity of bisphosphonates in human myeloma cells</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>32</api:text></api:field></api:native></api:record><api:record format="native" id="22202" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000078509300013" last-modified-when="2014-07-25T11:00:22.093+01:00"><api:citation-count>19</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Shipman</api:last-name><api:initials>CM</api:initials><api:first-names>CM</api:first-names><api:separate-first-names><api:first-name>C</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Rogers</api:last-name><api:initials>MJ</api:initials><api:first-names>MJ</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>JF</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Russell</api:last-name><api:initials>RGG</api:initials><api:first-names>RGG</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>G</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>PI</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>I</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1042-8194</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974230"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>1-2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>LEUKEMIA LYMPHOMA</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>multiple myeloma</api:keyword><api:keyword>bisphosphonates</api:keyword><api:keyword>apoptosis</api:keyword><api:keyword>bone disease</api:keyword><api:keyword>MULTIPLE-MYELOMA</api:keyword><api:keyword>IN-VITRO</api:keyword><api:keyword>BONE-RESORPTION</api:keyword><api:keyword>INDUCE APOPTOSIS</api:keyword><api:keyword>MACROPHAGE-LIKE</api:keyword><api:keyword>MARROW</api:keyword><api:keyword>GROWTH</api:keyword><api:keyword>CANCER</api:keyword><api:keyword>MALIGNANCIES</api:keyword><api:keyword>PHARMACOLOGY</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>129</api:begin-page><api:end-page>138</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>12</api:month><api:year>1998</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Anti-tumour activity of bisphosphonates in human myeloma cells</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>32</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Antineoplastic Agents</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Apoptosis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Bone Diseases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Cell Count</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Diphosphonates</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Multiple Myeloma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Survival</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Multiple Myeloma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Bone Diseases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Diphosphonates</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Antineoplastic Agents</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Cell Count</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Apoptosis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Survival</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3201 Cardiovascular Medicine and Haematology</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Rare Diseases</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Hematology</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Osteoporosis</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Cancer</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">5 Development of treatments and therapeutic interventions</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">5.1 Pharmaceuticals</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Cancer</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Musculoskeletal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Antineoplastic Agents</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Apoptosis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Bone Diseases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Cell Count</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Diphosphonates</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Multiple Myeloma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Survival</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Tumor Cells, Cultured</api:keyword><api:keyword origin="record-data" source="wos-lite">multiple myeloma</api:keyword><api:keyword origin="record-data" source="wos-lite">bisphosphonates</api:keyword><api:keyword origin="record-data" source="wos-lite">apoptosis</api:keyword><api:keyword origin="record-data" source="wos-lite">bone disease</api:keyword><api:keyword origin="record-data" source="wos">multiple myeloma</api:keyword><api:keyword origin="record-data" source="wos">bisphosphonates</api:keyword><api:keyword origin="record-data" source="wos">apoptosis</api:keyword><api:keyword origin="record-data" source="wos">bone disease</api:keyword><api:keyword origin="record-data" source="wos">MULTIPLE-MYELOMA</api:keyword><api:keyword origin="record-data" source="wos">IN-VITRO</api:keyword><api:keyword origin="record-data" source="wos">BONE-RESORPTION</api:keyword><api:keyword origin="record-data" source="wos">INDUCE APOPTOSIS</api:keyword><api:keyword origin="record-data" source="wos">MACROPHAGE-LIKE</api:keyword><api:keyword origin="record-data" source="wos">MARROW</api:keyword><api:keyword origin="record-data" source="wos">GROWTH</api:keyword><api:keyword origin="record-data" source="wos">CANCER</api:keyword><api:keyword origin="record-data" source="wos">MALIGNANCIES</api:keyword><api:keyword origin="record-data" source="wos">PHARMACOLOGY</api:keyword><api:keyword scheme="for" origin="issn-inferred">1103 Clinical Sciences</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Immunology</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3201 Cardiovascular medicine and haematology</api:keyword></api:keywords></api:all-labels><api:journal issn="1042-8194" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974230" title="Leukemia and Lymphoma"><api:records><api:record source-name="summary"><api:title>Leukemia and Lymphoma</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/57/relationships"/></api:object></api:result></api:response>